RayKnowChina Research Map
Shortlist0

RecruitingB-cell acute lymphoblastic leukaemiaPhase 3

Registered title, quoted from ClinicalTrials.gov

Newly-diagnosed Pediatric Ph-positive B-ALL Protocol

An open trial on B-cell acute lymphoblastic leukaemia, registered on ClinicalTrials.gov. Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC; 20 other hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 8 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Hospitals in mainland China listed for this trial 21

Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.

  1. Lead sponsorInstitute of Hematology & Blood Diseases Hospital, CAMS & PUMC中国医学科学院血液病医院(血液学研究所)TianjinHospital page
  2. Study siteAffiliated Hospital of Guizhou Medical University贵州医科大学附属医院GuiyangHospital page
  3. Study siteAffiliated Hospital of Qingdao University青岛大学附属医院QingdaoHospital page
  4. Study siteChildren's Hospital of Fudan University复旦大学附属儿科医院ShanghaiHospital page
  5. Study siteChildren's Hospital of Nanjing Medical University南京市儿童医院NanjingHospital page
  6. Study siteChildren's Hospital of Soochow University苏州大学附属儿童医院SuzhouHospital page
  7. Study siteChongqing Medical University Affiliated Children's Hospital重庆医科大学附属儿童医院ChongqingHospital page
  8. Study siteFirst Affiliated Hospital of Sun Yat-sen University中山大学附属第一医院GuangzhouHospital page
  9. Study siteFujian Medical University Union Hospital福建医科大学附属协和医院FuzhouHospital page
  10. Study siteGuangzhou Women and Children's Medical Center广州市妇女儿童医疗中心GuangzhouHospital page
  11. Study siteHunan Children's Hospital湖南省儿童医院ChangshaHospital page
  12. Study siteJiangxi Provincial Children's Hospital江西省儿童医院NanchangHospital page
  13. Study siteNanfang Hospital南方医科大学南方医院GuangzhouHospital page
  14. Study siteQilu Hospital of Shandong University山东大学齐鲁医院JinanHospital page
  15. Study siteShanghai Children's Hospital上海市儿童医院ShanghaiHospital page
  16. Study siteShenzhen Children's Hospital深圳市儿童医院ShenzhenHospital page
  17. Study siteThird Xiangya Hospital中南大学湘雅三医院ChangshaHospital page
  18. Study siteTongji Hospital华中科技大学同济医学院附属同济医院WuhanHospital page
  19. Study siteUnion Hospital华中科技大学同济医学院附属协和医院WuhanHospital page
  20. Study siteWest China Second University Hospital四川大学华西第二医院ChengduHospital page
  21. Study siteWuhan Children's Hospital武汉儿童医院WuhanHospital page

The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov

Source: ClinicalTrials.gov record NCT07152041, read on 8 Nov 2026; hospital names matched to this site’s hospital list. How names are matched

Checklist for this trial 1

Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.

Show the checklist (1 points)Hide the checklist
  1. 1 month to 18 years; sex: all

    Registered eligibility fields

Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; stage or severity, as the trial defines it; earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes; pregnancy, breastfeeding and contraception.

Questions to ask the study team

Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT07152041, read on 10 Nov 2026.

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria:

Must meet all items below:

  • Age older than 1 month to younger 18 years.
  • Newly diagnosed Philadelphia chromosome-positive or BCR::ABL1-positive B-ALL.
  • Written informed consent of the parents or other legally authorized guardian of the patient according to local law and regulations.

Exclusion Criteria:

Should be excluded if had any item below:

  • ALL evolved from CML.
  • Known underlying congenital immunodeficiency or metabolic disease.
  • Congenital heart disease with cardiac insufficiency.
  • Gastrointestinal dysfunction or gastrointestinal diseases that may significantly alter the absorption of study drug.
  • Severe malnutrition, uncontrolled active infections, or serious cardiovascular diseases.
  • Subjects with significant CNS disorder (e.g., uncontrolled seizure disorder, autoimmune disease involving CNS).
  • Treated with glucocorticoids for ≥14 days, or targeted inhibitor for > 7 days within one month before enrollment, or any chemotherapy or any systemic anticancer therapy (including but not limited to any TKI) or radiotherapy within 3 months before enrollment (except for emergency radiotherapy to relieve airway compression).
  • Any significant comorbidities or psychiatric disorders that may impact patient safety, compliance, informed consent, study participation, follow-up, or the interpretation of study results. In such cases, all participating sites must report directly to the PI to determine whether the patient meets exclusion criteria.

Quoted from ClinicalTrials.gov, NCT07152041, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT07152041, read on 8 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT07152041